Aortic aneurysms, chronic kidney disease and metalloproteinases

M Andreucci, M Provenzano, T Faga, A Michael… - Biomolecules, 2021 - mdpi.com
Metalloproteinases (MPs) are proteolytic enzymes involved in extracellular matrix
deposition, regulation of cellular signals of inflammation, proliferation, and apoptosis …

Sodium-glucose co-transporter-2 inhibitors and nephroprotection in diabetic patients: more than a challenge

M Provenzano, MC Pelle, I Zaffina, B Tassone… - Frontiers in …, 2021 - frontiersin.org
Diabetic nephropathy is the most common cause of end-stage renal disease worldwide.
Control of blood glucose and blood pressure (BP) reduces the risk of developing this …

The impact of chronic kidney disease on peripheral artery disease and peripheral revascularization

R Serra, UM Bracale, N Ielapi… - … Journal of General …, 2021 - Taylor & Francis
Chronic kidney disease (CKD) is a clinical condition characterized by high morbidity and
mortality. Globally, CKD is also increasing in prevalence and incidence. The two principal …

OMICS in chronic kidney disease: focus on prognosis and prediction

M Provenzano, R Serra, C Garofalo, A Michael… - International Journal of …, 2021 - mdpi.com
Chronic kidney disease (CKD) patients are characterized by a high residual risk for
cardiovascular (CV) events and CKD progression. This has prompted the implementation of …

Precision nephrology in patients with diabetes and chronic kidney disease

M Provenzano, F Maritati, C Abenavoli, C Bini… - International Journal of …, 2022 - mdpi.com
Diabetes is the leading cause of kidney failure and specifically, diabetic kidney disease
(DKD) occurs in up to 30% of all diabetic patients. Kidney disease attributed to diabetes is a …

Hypoxia-inducible factor stabilizers in end stage kidney disease:“can the promise be kept?”

G Crugliano, R Serra, N Ielapi, Y Battaglia… - International journal of …, 2021 - mdpi.com
Anemia is a common complication of chronic kidney disease (CKD). The prevalence of
anemia in CKD strongly increases as the estimated Glomerular Filtration Rate (eGFR) …

Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease

M Provenzano, M Andreucci, C Garofalo… - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Selective antagonists of Endothelin-1 receptors (ERA) have been
tested in diabetic and nondiabetic chronic kidney disease (CKD). The SONAR trial (Study Of …

Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records …

A Dashtban, MA Mizani, L Pasea, S Denaxas… - …, 2023 - thelancet.com
Background Although chronic kidney disease (CKD) is associated with high multimorbidity,
polypharmacy, morbidity and mortality, existing classification systems (mild to severe …

Low performance of prognostic tools for predicting death before dialysis in older patients with advanced CKD

J Prouvot, E Pambrun, V Antoine, C Couchoud… - Journal of …, 2022 - Springer
Introduction Chronic kidney disease (CKD) is a disease which is spreading worldwide,
especially among older patients. Several prognostic scores have been developed to predict …

Kidney damage and associated risk factors in the rural Eastern Cape, South Africa: A cross-sectional study

E Rosales Gonzalez, P Yogeswaran, J Chandia… - PloS one, 2024 - journals.plos.org
Background The colliding epidemic of infectious and non-communicable diseases in South
Africa could potentially increase the prevalence of kidney disease in the country. This study …